In September 2018, MDB Texinov® obtained the CE mark for its medical device Dynamic Light Therapy: FLUXMEDICARE®.
The FLUXMEDICARE® device consists of a luminous textile and a laser source to supply light.
This innovative system treats cutaneous lesions (actinic keratosis, pre-cancer of the skin) often developed after exposure without insufficient protection against the sun. A photo-sensitising cream is applied to the skin to be treated. The FLUXMEDICARE® textile is placed on the area thus prepared and illuminates it for 2½ hours. The injured skin cells absorb the cream and are destroyed when exposed to red light (photodynamic therapy).